Skip to main content
. 2022 Mar 7;1(2):61–66. doi: 10.1016/j.jacig.2022.02.001

Table I.

Clinical features of the general study population

Variable Level No. % Symptoms
ORc 95% CI P value
Severe
Mild
No. % No. %
Overall 395 100% 256 62% 139 33%
Sex Female 221 56% 79 57% 142 55% 1
Male 174 44% 60 43% 114 45% 1.1 0.6-1.6 .794
Age <14 y 32 8% 24 10% 8 6% 1
>14 y 359 92% 228 90% 131 94% 0.58 0.2-1.3 .193
Ara h 1 (7S globulin) No 269 84% 177 82% 92 87% 1
Yes 53 16% 39 18% 14 13% 1.44 0.7-2.8 .27
Ara h 2 (2S albumin) No 275 82% 170 78% 105 90% 1
Yes 60 18% 48 22% 12 10% 2.47 1.2-4.8 .007
Ara h 3 (11S globulin) No 268 88% 173 87% 95 91% 1
Yes 36 12% 27 14% 9 9% 1.65 0.7-3.6 .221
Ara h 6 (2S albumin) No 183 85% 120 82% 63 93% 1
Yes 32 15% 27 18% 5 7% 2.283 1.1-7.7 .035
Ara h 8 (PR-10) No 224 69% 169 78% 55 51% 1
Yes 100 31% 47 22% 53 49% 0.289 0.2-0.5 <.001
Ara h 9 (LTP) No 108 29% 63 26% 45 37% 1
Yes 262 71% 184 74% 78 63% 1.68 1.1-2.7 .027
Phl p 12 (profilin) No 226 82% 171 88% 55 66% 1
Yes 51 18% 23 12% 28 34% 0.264 0.1-0.5 <.001

Phl p, Phleum pratense.